SCM
NVAX icon

Sterling Capital Management’s Novavax NVAX Stock Holding History

Sterling Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.9K Buy
3,073
+1,396
+83% +$12.5K ﹤0.01% 1726
2026
Q1 		$13.7K Sell
1,677
-669
-29% -$6.06K ﹤0.01% 2209
2025
Q4 		$15.8K Buy
2,346
+219
+10% +$1.65K ﹤0.01% 2359
2025
Q3 		$18.4K Buy
2,127
+1,114
+110% +$8.67K ﹤0.01% 2185
2025
Q2 		$6.38K Buy
1,013
+285
+39% +$1.89K ﹤0.01% 2389
2025
Q1 		$4.67K Sell
728
-422
-37% -$3.49K ﹤0.01% 2197
2024
Q4 		$9.25K Buy
1,150
+926
+413% +$8.93K ﹤0.01% 2197
2024
Q3 		$2.83K Buy
+224
New +$2.89K ﹤0.01% 2022

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Sterling Capital Management's NVAX Position: Q2 2026 in Review

Sterling Capital Management increased its Novavax (NVAX) stake by 83% in Q2 2026, buying an estimated $12.5K and bringing the position to 3,073 shares worth $28.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1726.

Sterling Capital Management first reported a position in NVAX in Q3 2024 and has held it in 8 quarters since. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Sterling Capital Management held 3,073 shares of Novavax worth $28.9K as of Q2 2026.
  • Sterling Capital Management bought 1,396 Novavax shares in Q2 2026, an estimated $12.5K.
  • Novavax made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1726 holding.
  • Sterling Capital Management first reported a position in Novavax in Q3 2024 and has held it in 8 quarters since.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.